SkyePharma_NNP annual_JJ report_NN 2002_CD a_DT Reconciliation_NNP of_IN movements_NNS in_IN net_JJ debt_NN Year_NN to_TO Year_NN to_TO 31_CD December_NNP 2002_CD 31_CD December_NNP 2001 000 000_CD Decrease_NN in_IN cash_NN in_IN the_DT year_NN 176_CD 1,126_CD Cash_NN outflow_NN from_IN decrease_NN in_IN debt_NN and_CC lease_NN financing_NN 4,858_CD 5,454_CD Cash_NN outflow_NN inflow_NN from_IN increase_NN decrease_NN in_IN liquid_JJ resources_NNS 3,872_CD 14,668_CD Change_NNP in_IN net_JJ debt_NN resulting_VBG from_IN cash_NN flows_NNS 8,554_CD 10,340_CD Amortisation_NNP of_IN issue_NN costs_NNS on_IN convertible_JJ bonds_NNS 415_CD 416_CD Finance_NNP leases_VBZ acquired_VBN with_IN subsidiary_NN 361_CD New_NNP finance_NN leases_VBZ 91_CD 95_CD Chiron_NNP promissory_JJ note_NN 621_CD Translation_NN difference_NN 1,505_CD 21_CD Movement_NNP in_IN net_JJ debt_NN in_IN the_DT year_NN 5,561_CD 10,872_CD Net_JJ debt_NN at_IN beginning_NN of_IN the_DT year_NN 47,162_CD 36,290_CD Net_JJ debt_NN at_IN end_NN of_IN the_DT year_NN 41,601_CD 47,162_CD Net_JJ debt_NN is_VBZ defined_VBN as_IN cash_NN and_CC liquid_JJ resources_NNS less_RBR borrowings_NNS ._.
b_NN Reconciliation_NNP of_IN operating_NN profit_NN loss_NN to_TO net_JJ cash_NN inflow_NN from_IN operating_VBG activities_NNS Year_NN to_TO Year_NN to_TO 31_CD December_NNP 2002_CD 31_CD December_NNP 2001 000 000_CD Operating_NN profit_NN loss_NN 4,716_CD 5,099_CD Depreciation_NN 6,101_CD 4,778_CD Amortisation_NNP 6,506_CD 3,824_CD Decrease_NN increase_NN in_IN stock_NN and_CC work_NN in_IN progress_NN 1,022_CD 642_CD Increase_VBP in_IN debtors_NNS 21,585_CD 7,478_CD Increase_VBP in_IN deferred_JJ income_NN 6,339_CD 11,690_CD Decrease_NN increase_NN in_IN other_JJ creditors_NNS 313_CD 1,688_CD Increase_VBP decrease_NN in_IN provisions_NNS 133_CD 2,051_CD Other_JJ 1,367_CD 801_CD Net_JJ cash_NN inflow_NN from_IN operating_VBG activities_NNS 1,552_CD 5,909_CD notes_NNS to_TO the_DT consolidated_JJ 55_CD cash_NN flow_NN statement_NN c_NN Analysis_NN of_IN net_JJ debt_NN Acquisitions_NNS At_IN excluding_VBG At_IN 1_CD January_NNP Cash_NNP cash_NN and_CC Non-cash_JJ Exchange_NNP 31_CD December_NNP 2002_CD flow_NN overdrafts_NNS changes_NNS movements_NNS 2002 000 000 000_CD 000 000 000_CD Cash_NN at_IN bank_NN and_CC in_IN hand_NN 9,451_CD 1,828_CD 229_CD 7,394_CD Bank_NNP overdraft_NN 1,618_CD 1,652_CD 34_CD Short-term_JJ bank_NN deposits_NNS 17,441_CD 3,872_CD 646_CD 20,667_CD 25,274_CD 3,696_CD 909_CD 28,061_CD Debt_NN due_JJ within_IN one_CD year_NN 4,792_CD 2,992_CD 42_CD 1,842_CD Debt_NN due_JJ after_IN one_CD year_NN 7,961_CD 929 621 470_CD 8,123_CD Convertible_JJ bonds_NNS 57,962_CD 415_CD 58,377_CD Finance_NNP leases_NNS 1,721_CD 937_CD 361_CD 91_CD 84_CD 1,320_CD 72,436_CD 4,858_CD 1,127_CD 596_CD 69,662_CD Total_JJ 47,162_CD 8,554_CD 361_CD 1,127_CD 1,505_CD 41,601_CD Cash_NN at_IN bank_NN and_CC in_IN hand_NN and_CC short-term_JJ bank_NN deposits_NNS are_VBP aggregated_VBN on_IN the_DT balance_NN sheet_NN ._.
Debt_NN includes_VBZ a_DT bank_NN loan_NN ,_, secured_VBN mortgage_NN ,_, the_DT Chiron_NNP promissory_JJ note_NN and_CC convertible_JJ bonds_NNS ._.
See_VB note_NN 16_CD :_: Creditors_NNS :_: amounts_NNS falling_VBG due_JJ within_IN one_CD year_NN and_CC note_NN 17_CD :_: Creditors_NNS :_: amounts_NNS falling_VBG due_JJ after_IN more_JJR than_IN one_CD year_NN ._.
Non-cash_JJ changes_NNS relate_VBP to_TO the_DT amortisation_NN of_IN the_DT issue_NN costs_VBZ on_IN the_DT convertible_JJ bonds_NNS ,_, the_DT issue_NN of_IN the_DT Chiron_NNP promissory_JJ note_NN and_CC the_DT inception_NN of_IN new_JJ finance_NN leases_NNS ._.
notes_NNS to_TO the_DT consolidated_JJ 56_CD cash_NN flow_NN statement_NN continued_VBD SkyePharma_NNP annual_JJ report_NN 2002_CD
